Rheumatology at the Beach 2023

Rheumatology at the Beach 2023

Saturday, September 23, 2023; 8:30am - 3:00pm

Location: Sands Hotel, 1 N. Boardwalk Avenue, Rehoboth Beach, DE 19971

Registration is required.

Registration deadline: September 15, 2023

Questions? Please email: administrator@rheumatology-society-of-delaware.com

Event Overview

The Rheumatology Society of Delaware invites you to and attend our “2023 Rheumatology at the Beach meeting” The meeting offers an opportunity to reconnect and learn from top opinion leaders in our field.

Target Audience

This activity is intended for specialty physicians, primary care physicians, physician assistants, nurse practitioners, and medical students.

Statement of Need

There is a need to address rare medical conditions that are not commonly seen in critical practice. Therefore we are bringing specificalists to discuss cases and educate practioners in their expiernces. 

Educational Objectives

Upon completion of this activity learners should be able to:

1. Discuss updated set of guidelines in dealing with specific illness to better serve patients.
2. Discuss how some rare illnesses will/can present and better equip them to handling such cases. 
3. Equip providers with more tools to support patients.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and the Rheumatology Society of Delaware. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.

It is the policy of the Medical Society of Delaware (MSD) to comply with the ACCME Standards for Commercial Support of Continuing Medical Education (CME). In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.

Joint providership of CME by MSD in no way implies endorsement of any product or service. 

This activity is not supported by commercial funding.


 

Credit Designation Statement

The Medical Society of Delaware designates this live activity for a maximum of 4 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 24 months) with ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.

The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.

Jose A Pando, MD (Planner, Activity Director) - received consultant fee from Sanofi -  the financial relationships to do not relate to the educational assignment/presentation. All of the relevant financial relationships listed for this individual have been mitigated.
Fiona Pando, BS (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.

Allan Charles Gelber, MD, PhD, MPH (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.

Joel Kremer, MD, MACR, FACP (Speaker) - received consultant fee from Lilly; receives equity interest from CorEvitas -  the financial relationships to do not relate to the educational assignment/presentation. Best available published evidence will be used to support the presentation. All of the relevant financial relationships listed for this individual have been mitigated.

Rennie Rhee, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose

Rohit Aggarwal, MD (Speaker) - received research grants from Boehringer Ingelheim, Bristol-Myers Squibb, EMD Serono. Janssen, Mallinckrodt, Pfizer and Q32; received consulting fees from Actigraph, Alexion, ANI Pharmaceutical, Argenx, AstraZeneca, Boehringer Ingelheim, Bristol Myers-Squibb, CabaleetaBio, Capella, Corbus, CSL Behring, EMD Serono, Galapagos, Horizontal Therapeutics, I-Cell, Janssen, Kezar, Kyverna, Merck, Norvatis, Nuvig Therapeutic, Octapharma, Pfizer, Regeneron, Roivant, Sanofi and Teva -  All of the relevant financial relationships listed for this individual have been mitigated.

Disclaimer

All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this educational activity. No single reference or service can take the place of medical training, education and experience. This educational activity does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.

Technical Requirements

This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.